Scoring of PD-L1 in a Non-Small Cell Lung Cancer (NSCLC) Case

Join special guest, Philippe Taniére, as he reviews the basics of Tumor Proportion Score (TPS) assessment and walks through several cases of Non-small Cell Lung Cancer (NSCLC) stained with PD-L1 IHC 22C3 pharmDx. This video is great for those just starting out with PD-L1 evaluation using TPS.​

The Spotlight Video Series walks you through TPS principles and scoring strategies for cases stained with PD-L1 IHC 22C3 pharmDx. Through this engaging series, Agilent PD-L1 experts will help you to confidently:​

• Evaluate H&E, NCR, and PD-L1 slides for adequacy ​
• Understand inclusion/exclusion criteria and other core principles of Tumor Proportion Score (TPS)​
• Determine the best approaches for scoring cases based on specific characteristics and features​
• Navigate challenging morphology and staining characteristics​

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​​D0113769_1.00